Marburg vaccine shows promising results in first-in-human study
An experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Clinical Trials | Marburg Virus | National Institutes of Health (NIH) | Study | Vaccines